产品搜索 抗体高级搜索

首页 > 产品列表 > 细胞因子/重组蛋白/抗原 > 重组与天然蛋白质

Recombinant Mouse P-Cadherin

产品编号:C1359-100

产品描述:Recombinant Mouse P-Cadherin

反应种属:

实验方法:

标记:

规格:100ug

供应商:Leinco

价格(RMB):4875.00

订购:订购

说明书:

Recombinant Mouse Placental-Cadherin (P-Cad)
Purified No Carrier Protein
(Cadherin 3 (CDH3), CDHP, HJMD, PCAD)
Prod. No.: C1359
Source NSO Cells
Pkg. Size: 1 mg, 100 µg
Storage: -20°C to -70°C

Description
Background:

Cadherin 3, type 1, Placental-cadherin (P-cad), also known as CDH3 is a transmembrane protein involved in the cell-cell contact surface of basal keratinocytes and is homologous to E-cadherin.1 P-cad is expressed in placenta, epithelia, the basal cell of the skin, playing an important role in the morphogenesis of epidermis and skin appendage. The expression of P-cad in epithelial tissues appears to identify cell populations with proliferative activity, and its expression decreases as cells differentiate.1 P-cadherin, expressed in normal breast myoepithelial cells, has been reported in breast carcinomas, where it is associated with high-grade histological tumors and proliferation.2

Source
NSO Cells
Molecular Weight
The predicted molecular weight of Recombinant Mouse P-Cadherin is Mr 87.4` kDa. However, the actual molecular weight as observed by migration on SDS Page is Mr 120-130 kDa.
State of Matter
Lyophilized
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Purity
>90% by SDS-PAGE and analyzed by silver stain.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Endotoxin
<1.0 EU/µg as determined by the LAL method
Amino Acid Sequence

wv vapisvpeng kgpfpqrlnq lksnkdrdtk ifysitgpga dsppegvfav eketgwllln kpldreeiak yelfghavse ngasvedpmn isiivtdqnd hkpkftqdtf rgsvlegvlp gtsvmqvtat deddaiytyn gvvaysihsq epkdphdlmf tihrstgtis vissgldrek vpeytltiqa tdmdgdgstt tavavveild andnapmfdp qkyeahvpen avghevqrlt vtdldapnsp awratylimg gddgdhftit thpesnqgil ttrkgldfea knqhtlyvev tneapfvlkl ptstativvh vedvneapvf vppskvvevq egiptgepvc vytaedpdke nqkisyrilr dpagwlamdp dsgqvtavgt ldredeqfvr nniyevmvla mdngsppttg tgtllltlid vndhgpvpep rqiticnqsp vrhvlnitdk dlsphtspfq aqltddsdiy wtaevneegd tvvlslkkfl kqdtydvhls lsdhgnkeql tviratvcdc hghvetcpgp wkggiegrmd pkscdkthtc ppcpapellg gpsvflfppk pkdtlmisrt pevtcvvvdv shedpevkfn wyvdgvevhn aktkpreeqy nstyrvvsvl tvlhqdwlng keykckvsnk alpapiekti skakgqprep qvytlppsrd eltknqvslt clvkgfypsd iavewesngq pennykttpp vldsdgsffl yskltvdksr wqqgnvfscs vmhealhnhy tqkslslspg khhhhhh

References
1. Francesco Carinci et al. (2005) BMC Cancer 5: 63
2. Jerónimo C. et al. (2005) FEBS Journal 272